Clinical Leader Webinar

  1. How Advanced Therapies Are Changing The Landscape Of Rare Disease
    5/16/2019

    After years of innovative research, advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases – particularly for patients with rare diseases and orphan indications. In this webinar join experts from Medpace’s medical, regulatory and operational team with hands-on experience in rare disease and ATMP development as they explore scientific advancements the regulatory landscape and lessons-learned and best practices for operationalizing rare disease clinical trials including identifying, enrolling and retaining patients, as well as special considerations for ATMPs.

  2. Virtual Study Designs
    5/14/2019

    Virtual study designs are transforming the way biopharmaceutical businesses conduct research. Tactics that decentralize the approach to clinical and observational research are ushering in a new paradigm of efficient data collection and patient centric engagement.

  3. Recent FDA Updates And Guidance For Rare Disease Drug Development Webinar
    5/7/2019

    In January 2019, the US Food and Drug Administration (FDA) updated its 2015 draft guidelines for drug discovery in rare diseases. The update, Rare Diseases: Common Issues in Drug Development, seeks to help pharmaceutical companies and other sponsors perform more efficient development programs for drugs and biological products and provides new insights on complex elements of the development process. In this webinar, learn about the core elements of the new guidance plus the latest recommendations and instructions from the agency along with practical examples and applications.

  4. The Big Picture: Impact Of EU Disclosure On Small & Mid-Size Sponsors
    5/6/2019

    With the new EU clinical trial registry portal expected to launch next year, it’s imperative that sponsors – particularly small and mid-size organizations – understand the complexities of EU disclosure. Thomas Wicks, an expert in clinical trial disclosure, and Karen Rutkowski, an expert in medical writing, share actionable insights on compliance.

  5. CAR T Cell Therapy And Other Technologies Emerging In Oncology Research
    4/18/2019

    Some unique CAR T cell therapies have already been approved by the US Food and Drug Administration (FDA) and are the first steps toward further groundbreaking science. In this webinar, Emile Youssef, Premier Research’s Executive Medical Director, reviews the operational and clinical pathways that are helping to bring these technologies to patients.

  6. Webinar: What A Closed-Loop eClinical Stack Does For Clinical Trials
    4/15/2019

    In our webinar, Medrio’s DDC experts explore the key differences between multi-vendor and single-vendor eClinical solutions. Which approach empowers organizations to maximize the benefits of DDC?

  7. Overcoming Clinical Supply Chain Challenges In Investigator Initiated Studies
    4/12/2019

    Investigator Initiated Studies (IIS) offer pharmaceutical sponsor companies the benefit of increasing product knowledge and expanding the medical use of their drug. However, managing these studies presents unique clinical supply chain challenges and can become a very complex process. In this webinar, Almac’s clinical supply experts address these challenges and provide insight into how to best manage investigator initiated clinical studies.

  8. Optimizing Your Direct-To-Patient Clinical Trial Logistics Webinar
    3/27/2019

    Patient enrollment and retention remain a critical variable in clinical trial studies. Increasingly, sponsors are looking to the DTP trial model for certain patient populations, such as the elderly and critically ill. Watch this on-demand webinar and learn how to optimize your distribution chain for direct-to-patient clinical trials.

  9. eConsent: The Good, The Bad, And The Regulatory
    3/18/2019

    The clinical trial informed consent process is in dire need of optimization. High patient attrition rates indicate that we’re not doing enough to ensure patients truly understand the nature of their participation in clinical trials. We can do better. This webinar explains how organizations are using eConsent to enhance patient engagement, discusses regulatory considerations around eConsent, and more.

  10. eCOA Translations And Cultural Adaptation: Best Practices And Efficiencies
    3/15/2019

    While translation and cultural adaptation are time-intensive and require domain expertise, there are emerging best practices that not only save time, but also eliminate unnecessary work and reduce risk of error and timeline delays. his webinar will discuss the process of translation and cultural adaptation to support eCOA implementation on a global scale.